Spectrum Pharmaceuticals (SPPI)

Add to Watchlists Create an Alert
8.55 +0.12  +1.42%   NASDAQ May 23, 4:58PM BATS Real time Currency in USD

Spectrum Pharmaceuticals Revenue Quarterly YoY Growth:

32.32% for Dec. 31, 2012
View Full Chart

Spectrum Pharmaceuticals Revenue Quarterly YoY Growth Chart

    Spectrum Pharmaceuticals Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 32.32%
    Sept. 30, 2012 35.31%
    June 30, 2012 51.45%
    March 31, 2012 37.30%
    Dec. 31, 2011 56.07%
    Sept. 30, 2011 204.9%
    June 30, 2011 267.5%
    March 31, 2011 293.2%
    Dec. 31, 2010 293.8%
    Sept. 30, 2010 135.7%
    June 30, 2010 51.62%
    March 31, 2010 -21.70%
    Dec. 31, 2009 7.09%
    Sept. 30, 2009
    June 30, 2009 -60.63%
    March 31, 2009
    Dec. 31, 2008 17026%
    Sept. 30, 2008
    June 30, 2008 412.8%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    SPPI Revenue Quarterly YoY Growth Benchmarks

    Companies
    Elan 0.00%
    Agenus -91.71%
    Biocryst Pharmaceuticals -70.92%

    SPPI Revenue Quarterly YoY Growth Rankings

    Overall 92nd percentile
    616 of 8006
    Sector 85th percentile
    101 of 686 in Healthcare
    Industry 80th percentile
    48 of 248 in Biotechnology

    SPPI Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -60.63% Jun 2009
    Maximum 17026% Dec 2008
    Average 1176%